FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891191607> ?p ?o ?g. }

• W2891191607 abstract "Prostaglandins are products of the cyclooxygenase pathway, which is implicated in Parkinson’s disease (PD). Limited knowledge is available on mechanisms by which prostaglandins contribute to PD neurodegeneration. To address this gap, we focused on the prostaglandin PGD2/J2 signaling pathway, because PGD2 is the most abundant prostaglandin in the brain, and the one that increases the most under pathological conditions. Moreover, PGJ2 is spontaneously derived from PGD2. In this study, we determined in rats the impact of unilateral nigral PGJ2-microinfusions on COX-2, lipocalin-type PGD2 synthase (L-PGDS), PGD2/J2 receptor 2 (DP2), and 15 hydroxyprostaglandin dehydrogenase (15-PGDH). Nigral dopaminergic (DA) and microglial distribution and expression levels of these key factors of the prostaglandin D2/J2 pathway were evaluated by immunohistochemistry. PGJ2-induced motor deficits were assessed with the cylinder test. We also determined whether oral treatment with ibuprofen improved the PD-like pathology induced by PGJ2. PGJ2 treatment induced progressive PD-like pathology in the rats. Concomitant with DA neuronal loss in the substantia nigra pars compacta (SNpc), PGJ2-treated rats exhibited microglia and astrocyte activation and motor deficits. In DA neurons, COX-2, L-PGDS, and 15-PGDH levels increased significantly in PGJ2-treated rats compared to controls, while DP2 receptor levels were unchanged. In microglia, DP2 receptors were basically non-detectable, while COX-2 and L-PGDS levels increased upon PGJ2-treatment, and 15-PGDH remained unchanged. 15-PGDH was also detected in oligodendrocytes. Notably, ibuprofen prevented most PGJ2-induced PD-like pathology. The PGJ2-induced rat model develops progressive PD pathology, which is a hard-to-mimic aspect of this disorder. Moreover, prevention of most PGJ2-induced PD-like pathology with ibuprofen suggests a positive feedback mechanism between PGJ2 and COX-2 that could lead to chronic neuroinflammation. Notably, this is the first study that analyzes the nigral dopaminergic and microglial distribution and levels of factors of the PGD2/J2 signaling pathway in rodents. Our findings support the notions that upregulation of COX-2 and L-PGDS may be important in the PGJ2 evoked PD-like pathology, and that neuronal DP2 receptor antagonists and L-PGDS inhibitors may be novel pharmacotherapeutics to relieve neuroinflammation-mediated neurodegeneration in PD, circumventing the adverse side effects of cyclooxygenase inhibitors." @default.
• W2891191607 created "2018-09-27" @default.
• W2891191607 creator A5002140171 @default.
• W2891191607 creator A5011467883 @default.
• W2891191607 creator A5018435550 @default.
• W2891191607 creator A5019900484 @default.
• W2891191607 creator A5020127308 @default.
• W2891191607 creator A5024300994 @default.
• W2891191607 creator A5038247460 @default.
• W2891191607 date "2018-09-20" @default.
• W2891191607 modified "2023-10-17" @default.
• W2891191607 title "Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets" @default.
• W2891191607 cites W1510211954 @default.
• W2891191607 cites W1516704925 @default.
• W2891191607 cites W1566038319 @default.
• W2891191607 cites W1569924411 @default.
• W2891191607 cites W1933195856 @default.
• W2891191607 cites W1966388129 @default.
• W2891191607 cites W1966412118 @default.
• W2891191607 cites W1969604768 @default.
• W2891191607 cites W1972146241 @default.
• W2891191607 cites W1975774284 @default.
• W2891191607 cites W1976749972 @default.
• W2891191607 cites W1978818813 @default.
• W2891191607 cites W1980410293 @default.
• W2891191607 cites W1981573235 @default.
• W2891191607 cites W1982994872 @default.
• W2891191607 cites W1983769980 @default.
• W2891191607 cites W1985764043 @default.
• W2891191607 cites W1986862918 @default.
• W2891191607 cites W1988785687 @default.
• W2891191607 cites W1990195639 @default.
• W2891191607 cites W1991944268 @default.
• W2891191607 cites W1994659489 @default.
• W2891191607 cites W1999183933 @default.
• W2891191607 cites W1999722943 @default.
• W2891191607 cites W2003805676 @default.
• W2891191607 cites W2004701802 @default.
• W2891191607 cites W2006197047 @default.
• W2891191607 cites W2007127673 @default.
• W2891191607 cites W2016676102 @default.
• W2891191607 cites W2016928635 @default.
• W2891191607 cites W2017456596 @default.
• W2891191607 cites W2020656090 @default.
• W2891191607 cites W2020822045 @default.
• W2891191607 cites W2021745579 @default.
• W2891191607 cites W2030571587 @default.
• W2891191607 cites W2037752501 @default.
• W2891191607 cites W2038197998 @default.
• W2891191607 cites W2038636807 @default.
• W2891191607 cites W2050865611 @default.
• W2891191607 cites W2052004580 @default.
• W2891191607 cites W2054421268 @default.
• W2891191607 cites W2055750901 @default.
• W2891191607 cites W2056546282 @default.
• W2891191607 cites W2064202144 @default.
• W2891191607 cites W2069849992 @default.
• W2891191607 cites W2075680729 @default.
• W2891191607 cites W2075807462 @default.
• W2891191607 cites W2078915983 @default.
• W2891191607 cites W2079693092 @default.
• W2891191607 cites W2097830904 @default.
• W2891191607 cites W2099671309 @default.
• W2891191607 cites W2102668445 @default.
• W2891191607 cites W2105276495 @default.
• W2891191607 cites W2114395128 @default.
• W2891191607 cites W2116552323 @default.
• W2891191607 cites W2118021228 @default.
• W2891191607 cites W2120150976 @default.
• W2891191607 cites W2120412340 @default.
• W2891191607 cites W2129935236 @default.
• W2891191607 cites W2134723357 @default.
• W2891191607 cites W2144078756 @default.
• W2891191607 cites W2146736698 @default.
• W2891191607 cites W2153092987 @default.
• W2891191607 cites W2157151225 @default.
• W2891191607 cites W2157587576 @default.
• W2891191607 cites W2159575294 @default.
• W2891191607 cites W2160634538 @default.
• W2891191607 cites W2161329380 @default.
• W2891191607 cites W2166735794 @default.
• W2891191607 cites W2172040530 @default.
• W2891191607 cites W2310305711 @default.
• W2891191607 cites W2338945407 @default.
• W2891191607 cites W318793304 @default.
• W2891191607 cites W4234799259 @default.
• W2891191607 cites W4239908405 @default.
• W2891191607 cites W4255166647 @default.
• W2891191607 cites W4366658071 @default.
• W2891191607 cites W13460065 @default.
• W2891191607 doi "https://doi.org/10.1186/s12974-018-1305-3" @default.
• W2891191607 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6146649" @default.
• W2891191607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30236122" @default.
• W2891191607 hasPublicationYear "2018" @default.
• W2891191607 type Work @default.
• W2891191607 sameAs 2891191607 @default.
• W2891191607 citedByCount "15" @default.
• W2891191607 countsByYear W28911916072019 @default.
• W2891191607 countsByYear W28911916072020 @default.
• W2891191607 countsByYear W28911916072021 @default.

• next